These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15383703)

  • 1. The anthracycline antitumor agents doxorubicin and daunorubicin reduce the activity of Candida albicans phospholipase B.
    Arai R; Sugita T; Nishikawa A
    Microbiol Immunol; 2004; 48(9):665-7. PubMed ID: 15383703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
    Gewirtz DA
    Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
    Muszyńska A; Wolczyński S; Pałka J
    Eur J Pharmacol; 2001 Jan; 411(1-2):17-25. PubMed ID: 11137854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between phospholipase of Candida albicans and resistance to fluconazole.
    Ying S; Chunyang L
    Mycoses; 2012 Jan; 55(1):50-5. PubMed ID: 21623950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract]   [Full Text] [Related]  

  • 6. Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B.
    O'Keeffe J; Doyle S; Kavanagh K
    J Pharm Pharmacol; 2003 Dec; 55(12):1629-33. PubMed ID: 14738588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1996 Oct; 39(21):4135-8. PubMed ID: 8863788
    [No Abstract]   [Full Text] [Related]  

  • 9. Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
    Kaaijk P; Troost D; de Boer OJ; Van Amstel P; Bakker PJ; Leenstra S; Bosch DA
    Br J Cancer; 1996 Jul; 74(2):187-93. PubMed ID: 8688320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of effects of two antitumor anthracycline analogs on the pathway of activation of PKC in intact human platelets.
    Lanzi C; Banfi P; Ravagnani F; Gambetta RA
    Biochem Pharmacol; 1988 Sep; 37(18):3497-504. PubMed ID: 2844190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
    Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis.
    Anil S; Samaranayake LP
    Chemotherapy; 2003 Sep; 49(5):243-7. PubMed ID: 14504435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
    Babudri N; Pani B; Tamaro M; Monti-Bragadin C; Zunino F
    Br J Cancer; 1984 Jul; 50(1):91-6. PubMed ID: 6378238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enantioselective synthesis of anthracyclines].
    Monneret C
    Ann Pharm Fr; 1997; 55(1):5-11. PubMed ID: 9138316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
    Skovsgaard T
    Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics.
    Cheng CC; Zbinden G; Zee-Cheng RK
    J Pharm Sci; 1979 Mar; 68(3):393-6. PubMed ID: 423142
    [No Abstract]   [Full Text] [Related]  

  • 17. Intracellular glutathione as a determinant of responsiveness to antitumor drugs.
    Romine MT; Kessel D
    Biochem Pharmacol; 1986 Oct; 35(19):3323-6. PubMed ID: 3464280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
    Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
    J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocimum sanctum essential oil inhibits virulence attributes in Candida albicans.
    Khan A; Ahmad A; Xess I; Khan LA; Manzoor N
    Phytomedicine; 2014 Mar; 21(4):448-52. PubMed ID: 24252340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of doxorubicin and daunorubicin on the activity of acetylcholinesterase in acute lymphoblastic leukamia.
    Niazi IU; Tariq SA; Ali A
    J Ayub Med Coll Abbottabad; 2011; 23(2):45-7. PubMed ID: 24800340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.